Navigation Links
MIT Holding, Inc. signs partnership agreement with Georgia Southern University
Date:10/2/2007

SAVANNAH, Ga.October 2, 2007, MIT Holding, Inc. (OTCBB: MITD - News), has signed an agreement with Georgia Southern University to research products to stop the spread of infectious diseases. Dr. Thomas M. Kollars, Jr., the Company's Chief Scientific Advisor and Director of the Biodefense and Infectious Disease Laboratory and Associate Professor of Epidemiology in the Jiann-Ping Hsu College of Public Health, Georgia Southern University, will oversee the project.

This is a significant partnership for MIT Holding, commented William C. Parker, Chief Executive Officer of MIT Holding. Georgia Southern University has extensive experience in public health research and well documented clinical data that will support our program. We look forward to working with Dr. Kollars and his team of experts to develop a product that could potentially save millions of lives through stopping the spread of infectious diseases, including malaria, dengue fever and West Nile virus.

We share the same ambition as MIT to stop the spread of infectious diseases, commented Dr. Kollars. The effects of infectious diseases are widespread, and account for millions of deaths every year. We have worked extensively to understand the epidemiology of these diseases, and are close to finalizing a product that could potentially save millions of lives. MIT has a strong distribution network and years of experience compounding pharmaceuticals. We look forward to working with the team at MIT to conclude the last component of our research, which we believe will create a commercially available product that will help eradicate infectious diseases within geographic areas.


'/>"/>

Contact: Janet Vasquez
jvasquez@investorrelationsgroup.com
212-825-3210
MIT Holding/Mevlabs
Source:Eurekalert

Page: 1

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
Breaking Medicine Technology: